Abiopharma

Clinical trial NCT05683457 updates: 1. completion date: 2026-08-01 → 2027-03-06 2. primary completion date: 2026-08-01 → 2027-03-06

Clinical trial NCT07513662 updates: 1. start date: 2026-09-01 → 2026-10-01 2. completion date: 2028-08-01 → 2028-12-01 3. primary completion date: 2028-06-01 → 2028-08-01

Clinical trial NCT07543055: start date: 2026-07-07 → 2026-08-10.

Clinical trial NCT07504601: start date: 2026-08-12 → 2026-08-13.

Clinical trial NCT06174805 updates: 1. completion date: 2027-04-01 → 2027-09-01 2. primary completion date: 2027-03-01 → 2027-08-01

Clinical trial NCT06693843 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-08-01 → 2026-07-09 3. enrollment: 220 → 230 participants 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06840834: primary completion date: 2026-03-24 → 2026-09-30.

Clinical trial NCT07704658: start date: 2026-06-01 → 2026-03-04.

Clinical trial NCT06880549: status: ACTIVE_NOT_RECRUITING → RECRUITING.

Clinical trial NCT05818098 updates: 1. status: UNKNOWN → COMPLETED 2. completion date: 2024-03-01 → 2023-09-15 3. primary completion date: 2023-09-01 → 2023-09-15 4. enrollment type: ESTIMATED → ACTUAL 5. collaborators added: Shengjing Hospital, The People's Hospital of Liaoning Province, Wuhan Central Hospital, Xiamen Cardiovascular Hospital, Xiamen University, Shanxi Bethune Hospital, …